Thromb Haemost 1999; 82(06): 1774-1775
DOI: 10.1055/s-0037-1614917
Letters to the Editor
Schattauer GmbH

High Levels of IgA Anticardiolipin Antibodies in Patients with Systemic Lupus erythematosus, Henoch-Schoenlein Purpura, Sneddon’s Syndrome and Recurrent Pregnancy Loss

Marta Baleva
1   From the University Alexander Hospital, Faculty of Medicine, Medical University, Sofia, Bulgaria
,
Boris Boyanovsky
1   From the University Alexander Hospital, Faculty of Medicine, Medical University, Sofia, Bulgaria
,
Krasimir Nikolov
1   From the University Alexander Hospital, Faculty of Medicine, Medical University, Sofia, Bulgaria
,
Zlatimir Kolarov
1   From the University Alexander Hospital, Faculty of Medicine, Medical University, Sofia, Bulgaria
,
Milena Nikolova
1   From the University Alexander Hospital, Faculty of Medicine, Medical University, Sofia, Bulgaria
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 11. Februar 1999

Accepted after resubmission 24. März 1999

Publikationsdatum:
10. Dezember 2017 (online)

 

 
  • References

  • 1 Selva-O’Callaghan A, Ordi-Ros J, Monegal-Ferran M, Martinez N, Cortes-Hernandes F, Vilardell-Tarres M. IgA anticardiolipin antibodies-relation with other antiphospholipid antibodies and clinical significance. Thromb Haemost 1998; 79: 282-5.
  • 2 Branch DW, Silver RM. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss?. Lupus 1996; 5: 409-13.
  • 3 Loizou LR, Cifiner A, Weetman AP, Walport MJ. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol 1992; 90: 434-9.
  • 4 Tomas JF, Alberca I, Tabernero MD, Cordero M, Del Pino-Montes J, Vicente V. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1998; 25: 57-62.
  • 5 Weidman CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 1988; 15: 74-9.
  • 6 Baleva M, Chauchev A, Dikova C, Stamenov B, Nikoevsky N, Tzankov N, Nikolov K. Sneddon’s syndrome: echocardiographic, neurological and immunological findings. Stroke 1995; 26: 1303-4.
  • 7 Ames PR, Pyke S, Iannaccone L, Brancaccio V. Antiphospholipid antibodies, haemostatic variables and thrombosis-a survey of 144 patients. Thromb Haemost 1995; 73: 768-73.
  • 8 Burden AD, Tillman DM, Foley P, Holme E. IgA class anticardiolipin antibodies in cutaneous vasculitis. J Am Acad Dermatol 1996; 35: 411-5.
  • 9 Lopez LR, Santos ME, Espinosa LR. et al. Clinical significance of immunoglobulin A versus immunoglobulin G and M anticardiolipin antibodies in patients with systemic lupus erythematosus. Am J Clin Pathol 1992; 98: 449-54.
  • 10 Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M. High frequency of abnormal levels of IgA anti-β2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J Rheumatol 1998; 25: 675-80.
  • 11 Knight JF, Harada T, Thomas MAB, Frampton G, Savage COS, Chantler C, Williams DG. IgA rheumatoid factor and other autoantibodies in acute Henoch-Schoenlein purpura. Contr Nephrol 1988; 67: 117-20.